SIDDHARTH BAJPAI: Open Payments
NPI 1093945727 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,968 in 92 payments from 17 companies in 2025. Trend: 2023 $1,906 · 2024 $1,594 · 2025 $1,968
Food & beverage: $1,941Education: $27
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $341 |
| Vanda Pharmaceuticals Inc. | 14 | $293 |
| Axsome Therapeutics, Inc. | 11 | $266 |
| Lundbeck LLC | 6 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $156 |
| Bausch Health US, LLC | 5 | $94 |
| Supernus Pharmaceuticals, Inc. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
| HARMONY BIOSCIENCES LLC | 3 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
Products named: REXULTI, Auvelity, HETLIOZ, TRINTELLIX, FANAPT, APLENZIN, Qelbree, COBENFY.
Industry payments across VA — which companies pay providers there.
